Despite a 20-year head start, providers still fall short of HIPAA requirements around fulfilling patient requests for their medical records. In light of the federal information blocking rules, providers should first examine their compliance with HIPAA and then address the new demands imposed by the recently enacted regulations.
The federal price transparency rule for hospitals went into effect Jan. 1, but a new analysis shows that a majority of providers studied were "unambiguously noncompliant."
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Many players in life sciences and other sectors balk at updating their compliance systems because of the cost and resources involved, but addressing possible lapses now can save your company millions of dollars in fines and reputational damage.
The Office of the Inspector General will audit Medicare Part B telehealth services to detect potential vulnerabilities and ensure compliance with regulatory requirements. To prepare, providers must first take stock of their programs and conduct audits of their own, experts say.
CMS has finalized changes to the Physician Self-Referral Law, also known as Stark Law. Healthcare law experts say that these changes will generally make it easier for hospitals and physicians to remain in compliance with the statute.
The combined company will retain the Datica name and is headquartered in Minneapolis. Sansoro Health CEO Jeremy Pierotti will take on the chief executive role of the new company and former Datica CEO Travis Good will move to the position of chief technology officer.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The implementation of data regulations and an enforcing oversight committee can have a great impact and encourage many trial sponsors to become more transparent with their trials.
Don’t be like Acme Medical Device Company.
This is a story I recently heard from a medical device startup who lost over $400,000 dealing with the aftermath of an FDA compliance inspection.